Shiri, T.; Evans, M.; Talarico, C.A.; Morgan, A.R.; Mussad, M.; Buck, P.O.; McEwan, P.; Strain, W.D.
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines 2022, 10, 140.
https://doi.org/10.3390/vaccines10020140
AMA Style
Shiri T, Evans M, Talarico CA, Morgan AR, Mussad M, Buck PO, McEwan P, Strain WD.
The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines. 2022; 10(2):140.
https://doi.org/10.3390/vaccines10020140
Chicago/Turabian Style
Shiri, Tinevimbo, Marc Evans, Carla A. Talarico, Angharad R. Morgan, Maaz Mussad, Philip O. Buck, Phil McEwan, and William David Strain.
2022. "The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program" Vaccines 10, no. 2: 140.
https://doi.org/10.3390/vaccines10020140
APA Style
Shiri, T., Evans, M., Talarico, C. A., Morgan, A. R., Mussad, M., Buck, P. O., McEwan, P., & Strain, W. D.
(2022). The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program. Vaccines, 10(2), 140.
https://doi.org/10.3390/vaccines10020140
